Screening strategies in surveillance and control of methicillin-resistant Staphylococcus aureus (MRSA)

Epidemiology and Infection

Volumn 135, Issue 2, 2007, Pages 328-342

  Robotham, J V ^a,b   Jenkins, D R ^b   Medley, G F ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIC; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; QUANTITATIVE ANALYSIS; SCREENING TEST; STAPHYLOCOCCUS INFECTION; STOCHASTIC MODEL;

CROSS INFECTION; HUMANS; INFECTION CONTROL; MASS SCREENING; MATHEMATICS; METHICILLIN RESISTANCE; POPULATION SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33847329671     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880600687X     Document Type: Article

References (32)

1. Anon. First report of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS Trusts in England: April-September 2001. Communicable Disease Report Weekly 2002; 12(6).
2. Anon. The third year of regional and national analyses of the Department of Health's mandatory MRSA surveillance scheme in England: April 2001-March 2004. Communicable Disease Report Weekly 2004; 14(29).
3. Cooper BS, et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): Systematic review of the literature. British Medical Journal 2004; 329: 533.
4. Cooper BS, et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: A review of the literature with epidemiological and economic modelling. Health Technology Assessment 2003; 7(39).
5. Ayliffe GAJ, et al. Revised methicillin-resistant Staphylococcus aureus infection control guidelines for hospitals. Report of a combined working party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association, prepared by G. Duckworth, B. Cookson, H. Humphreys and R. Heathcock. Journal of Hospital Infection 1998; 39: 253-290.
6. Coello R, et al. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. Journal of Hospital Infection 1997; 37: 39-46.
7. Cookson B. Controversies: Is it time to stop searching for MRSA? (Screening is still important). British Medical Journal 1997; 314: 664.
8. Farr BM. Prevention and control of methicillin-resistant Staphylococcus aureus infections. Current Opinion in Infectious Diseases 2004; 17: 317-322.
9. Lepelletier D, et al. Which strategies follow from the surveillance of multidrug-resistant bacteria to strengthen control of their spread? A French experience. Infection Control Hospital Epidemiology 2004; 25: 162-164.
10. Austin DJ, Anderson RM. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales. Journal of Infectious Diseases 1999; 179: 883-891.
11. Austin DJ, Anderson RM. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Philosophical Transactions of the Royal Society of London, B: Biological Sciences 1999; 354: 721-738.
12. Austin DJ, et al. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs. Proceedings of the National Academy of Sciences USA 1999; 96: 6908-6913.
13. Bonten MJM, Austin DJ, Lipsitch M. Understanding the spread of antibiotic resistant pathogens in hospitals: Mathematical models as tools for control. Clinical Infectious Diseases 2001; 33: 1739-1746.
14. Grundmann H, et al. Risk factors for the transmission of MRSA in an adult intensive care unit: Fitting a model to the data. Journal of Infectious Diseases 2002; 185: 481-488.
15. Levin BR. Minimizing potential resistance: A population dynamics view. Clinical Infectious Diseases 2001 33 (Suppl. 3): S161-169.
16. Lipsitch M, Bergstrom CT, Levin BR. The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions. Proceedings of the National Academy of Sciences USA 2000; 97: 1938-1943.
17. Sébille V, Chevret S, Valleron AJ. Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. Infection Control and Hospital Epidemiology 1997; 18: 84-92.
18. Cooper BS, Medley GF, Scott GM. Preliminary analysis of the transmission dynamics of nosocomial infections: Stochastic and management effects. Journal of Hospital Infection 1999; 43: 131-147.
19. Cooper BS, et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: Stealth dynamics and control catastrophes. Proceedings of the National Academy of Sciences USA 2004; 101: 10223-10228.
20. Salgado CD, Farr BNL Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clinical Infectious Diseases 2003; 36: 131-139.
21. Casewell NM. New threats to the control of methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection 1996; 30 (Suppl.): 465-471.
22. Chaix C, et al. Control of endemic methicillin-resistant Staphylococcus aureus. A cost-benefit analysis in an intensive care unit. Journal of the American Medical Association 1999; 282: 1745-1751.
23. Papia G, et al. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: Is it cost effective? Infection Control and Hospital Epidemiology 1999; 20: 473-477.
24. Coello R, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. European Journal of Clinical Microbiology and Infectious Diseases 1994; 13: 74-81.
25. van Saene HKF, et al. MRSA - time for a more pragmatic approach? Journal of Hospital Infection 2004; 56: 170-174.
26. Girou E, et al. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clinical Infectious Diseases 1998; 27: 543-550.
27. Girou E, et al. Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carnage in a high-risk dermatology ward. Infection Control and Hospital Epidemiology 2000; 21: 583-587.
28. Blok HE, et al. Role of healthcare workers in outbreaks of, methicillin-resistant Staphylococcus aureus: A 10-year evaluation from a Dutch university hospital. Infection Control and Hospital Epidemiology 2003; 24: 679-685.
29. Drinka PJ, et al. Screening for methicillin-resistant Staphylococcus aureus in a nursing home. Infection Control and Hospital Epidemiology 2004; 25: 95-96.
30. Kunori T, et al. Cost-effectiveness of different MRSA screening methods. Journal of Hospital Infection 2002; 51: 189-200.
31. Smith DL, et al. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: Resistance is a regional problem. Proceedings of the National Academy of Sciences USA 2004; 101: 3709-3714.
32. Smith DL, Levin SA, Laxminarayan R. Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proceedings of the National Academy of Science USA 2005; 102: 3153-3158.